200
Participants
Start Date
December 22, 2023
Primary Completion Date
December 1, 2026
Study Completion Date
May 31, 2027
Autologous blood patch pleurodesis
The intervention in this study is distinguished by the fact that patients are randomized, the dose of both glucose and ABPP is 120 ml, the patient remains in a supine position for 2 hours after administration, the procedure can be repeated at 48-hour intervals, a maximum of 3 times.
40% glucose solution pleurodesis
"After obtaining informed consent, the patient will lie supine in their room. 30 minutes before the procedure, the patient's capillary blood glucose level will be measured. The patient does not have to fast before the procedure. The nurse will be asked to collect 120 ml of peripheral venous blood from the patient. Then the doctor, assisted by the nurse, will first administer 20 ml of 1% Lignocaine through the pleural drain, and then after about 5-10 minutes, the patient's previously collected venous blood. At the moment of blood administration, the drainage system will be disconnected. Then, the drain will be injected with 20 ml of air to avoid clogging the drain. The patient will remain supine for two hours post-procedure, maintaining fasting status. After 30 minutes from the administration of the patient's own blood, the capillary blood glucose level will be measured again. After two hours, the patient, with nursing assistance, may resume normal activities."
RECRUITING
Wielkopolskie Centrum Pulmonologii i Torakochirurgii, Poznan
Poznan University of Medical Sciences
OTHER
Wielkopolskie Centrum Pulmonologii i Torakochirurgii
OTHER